News & Analysis on Clinical Trial Services & Contract Research And Development
Patheon hopes that a new pharmaceutical development services (PDS) suite at its facility in Whitby, Ontario will complete its “Quick to Clinic” offering and provide a rapid-response means of making solid dosage forms for trials.
Irish drugmaker Elan has shelved plans to sell its contracting arm EDT in favour of improving the division’s profitability, despite receiving what it describes as “considerable interest” in the unit.
in-PharmaTechnologist.com presents its latest round up of personnel moves in pharmaceutical manufacturing, including major restructuring at Novartis.
David Hipkiss explains the benefits for pharmaceutical manufacturers of using Prosonix’ sonocrystallisation technology.
Sun Pharmaceutical has posted a strong set of results for the second quarter of fiscal 2009, driven by improved performance by both its Indian branded drug and US generics businesses.
Cognizant will provide maintenance services to AstraZeneca’s research, clinical development, sales and marketing, over a five-year period.